These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3907031)

  • 1. Successful transplantation of cyclosporine-treated allograft recipients with serologically positive historical, but negative preoperative, donor crossmatches.
    Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
    Transplantation; 1985 Dec; 40(6):615-9. PubMed ID: 3907031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AHG and DTE/AHG procedure identification of crossmatch-appropriate donor-recipient pairings that result in improved graft survival.
    Kerman RH; Kimball PM; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Heydari A; Kahan BD
    Transplantation; 1991 Feb; 51(2):316-20. PubMed ID: 1994522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients.
    Kerman RH; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Gerolami K; Kahan BD
    Transplantation; 1990 Jan; 49(1):52-6. PubMed ID: 2301027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine.
    Kerman RH; van Buren CT; Lewis RM; Frazier OH; Cooley D; Kahan BD
    Transplantation; 1988 Feb; 45(2):333-7. PubMed ID: 3278425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful transplantation of 100 untransfused cyclosporine-treated primary recipients of cadaveric renal allografts.
    Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplantation; 1988 Jan; 45(1):37-40. PubMed ID: 3276059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of HTLV-3 serology in a renal transplant population.
    Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Dawson G; Falk L; Gutierrez R; Hollinger JB; Kahan BD
    Transplantation; 1987 Feb; 43(2):244-8. PubMed ID: 3544383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients.
    Kerman RH; Kimball PM; Van Buren CT; Lewis RM; Kahan BD
    Transplantation; 1991 Feb; 51(2):338-42. PubMed ID: 1825242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival.
    Kerman RH; Kimball PM; Lindholm A; Van Buren CT; Katz SM; Lewis RM; McClain J; Podbielski J; Williams J; Kahan BD
    Transplantation; 1993 Nov; 56(5):1242-7. PubMed ID: 8249130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome.
    Kerman RH; Susskind B; Buyse I; Pryzbylowski P; Ruth J; Warnell S; Gruber SA; Katz S; Van Buren CT; Kahan BD
    Transplantation; 1999 Dec; 68(12):1855-8. PubMed ID: 10628764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulatory mechanisms in cyclosporine-treated renal allograft recipients.
    Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
    Transplantation; 1987 Feb; 43(2):205-10. PubMed ID: 2949404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients.
    Barber WH; Hudson SL; Deierhoi MH; Laskow DA; Gaston RS; Julian BA; Curtis JJ; Diethelm AG
    Clin Transpl; 1990; ():289-300. PubMed ID: 2103152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
    Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
    Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.
    Katz SM; Kimball PM; Ozaki C; Monsour H; Clark J; Cavazos D; Kahan BD; Wood RP; Kerman RH
    Transplantation; 1994 Feb; 57(4):616-20. PubMed ID: 8116049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship among donor-recipient HLA mismatches, rejection, and death from coronary artery disease in cardiac transplant recipients.
    Kerman RH; Kimball P; Scheinen S; Radovancevic B; Van Buren CT; Kahan BD; Frazier OH
    Transplantation; 1994 Mar; 57(6):884-8. PubMed ID: 8154036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of graft loss beyond two years in the cyclosporine era.
    Dunn J; Golden D; Van Buren CT; Lewis RM; Lawen J; Kahan BD
    Transplantation; 1990 Feb; 49(2):349-53. PubMed ID: 2305464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-Cell crossmatching and kidney allograft outcome in 9031 United States transplant recipients.
    Mahoney RJ; Taranto S; Edwards E
    Hum Immunol; 2002 Apr; 63(4):324-35. PubMed ID: 12039415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional immunosuppression after deliberate third party transfusions versus cyclosporine in living related renal transplant recipients.
    Hodge EE; Banowsky LH; Novick AC; Lewis RM; Streem SB; Steinmuller DR; Holzmann JJ; McFarlin L; Graneto DE
    J Urol; 1989 Mar; 141(3):495-8. PubMed ID: 2645417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine as primary therapy for A-matched living related donor kidney graft recipients.
    MacDonald AS; Belitsky P; Bitter-Suermann H; Cohen A
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1667-9. PubMed ID: 2652546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-identical renal transplants: impact of cyclosporine on intermediate-term survival and renal function.
    Sumrani N; Delaney V; Ding ZK; Butt K; Hong J
    Am J Kidney Dis; 1990 Nov; 16(5):417-22. PubMed ID: 2239931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.